Skip to main content
. 2021 Jun 16;9:689919. doi: 10.3389/fpubh.2021.689919

Table 4.

Sociodemographic and health-related characterisation of NOVA University subjects, stratified based on mental health assessment results.

Total (n = 1,627) Presence of depression (n = 32) Presence of anxiety (n = 121)
Sex n = 1,627 n = 32 n = 121
Female 1,074 (66.0%) 27 (84.4%) 106 (87.6%)
Male 553 (34.0%) 5 (15.6%) 15 (12.4%)
Age Group n = 1,619 n = 32 n = 121
<30 297 (18.3%) 3 (9.4%) 28 (23.1%)
(30, 39) 438 (27.1%) 7 (21.9%) 30 (24.8%)
(40, 49) 414 (25.6%) 10 (31.3%) 36 (30.0%)
(50, 59) 310 (19.1%) 10 (31.3%) 20 (16.5%)
≥60 160 (9.9%) 2 (6.2%) 7 (5.8%)
Academic degree n = 1,560 n = 31 n = 120
PhD 634 (40.6%) 13 (42.0%) 47 (39.2%)
MSc 381 (24.4%) 9 (29.0%) 29 (24.2%)
BD 344 (22.1%) 4 (12.9%) 30 (25.0%)
Secondary School 131 (8.4%) 5 (16.1%) 20 (8.3%)
High School 43 (2.7%) 4 (3.3%)
Complete primary school 25 (1.6%)
Primary School 2 (0.1%)
Faculty/Institute n = 1,601 n = 32 n = 117
ENSP 40 (2.5%) 1 (3.1%) 3 (2.6%)
NMS 240 (15.0%) 8 (6.8%)
FCSH 197 (12.3%) 6 (18.8%) 19 (16.2%)
FCT 448 (27.9%) 13 (40.6%) 32 (27.4%)
FD 31 (1.9%) 7 (6.0%)
IHMT 46 (2.9%) 2 (6.2%) 3 (2.6%)
ITQB/IBET 290 (18.1%) 4 (12.5%) 25 (21.4%)
RUNL 114 (7.1%) 1 (3.1%) 9 (7.7%)
SBE 195 (12.2%) 5 (15.6%) 11 (9.4%)
Body Mass Index (kg/m2) n = 1,586 n = 31 n = 118
Underweight (<18.5) 44 (2.8%) 1 (3.2%) 4 (3.4%)
Normal (18.5–24.9) 912 (57.5%) 16 (51.6%) 69 (58.5%)
Overweight (25–29.9) 475 (30.0%) 8 (25.8%) 28 (23.7%)
Obese (≥30) 155 (9.8%) 6 (19.4%) 17 (14.4%)
Occupational group n = 1,562 n = 30 n = 118
Armed Forces 1 (0.1%)
Executives/Directors/Managers 42 (2.7%) 5 (4.2%)
Scientific and Intellectual Areas 1,275 (81.6%) 21 (70.0%) 84 (71.2%)
Middle level 73 (4.7%) 2 (6.7%) 5 (4.2%)
Administrative 98 (6.3%) 4 (13.3%) 7 (5.9%)
Personal Services 20 (1.3%) 1 (0.9%)
Agriculture/Fishing
Industry/Construction 8 (0.5%) 3 (2.5%)
Machine operators
Non-qualified workers 45 (2.9%) 3 (10.0%) 13 (11.0%)
Smoking n = 1,611 n = 32 n = 120
Never 910 (56.5%) 14 (43.8%) 55 (45.8%)
Daily 214 (13.3%) 7 (21.9%) 21 (17.5%)
Occasionally 101 (6.3%) 3 (0.4%) 11 (9.2%)
In the past 380 (23.6%) 8 (25.0%) 32 (26.7%)
DK/DA 6 (0.4%) 1 (0.8%)
Alcohol n = 1,595 n = 32 n = 121
Never 198 (12.4%) 9 (28.1%) 19 (15.7%)
Daily 131 (8.2%) 1 (3.1%) 8 (6.6%)
Occasionally 1,257 (78.8%) 22 (68.8%) 94 (77.7%)
DK/DA 9 (0.6%)
Comorbidities n = 1,627 n = 32 n = 121
No 591 (36.3%) 4 (12.5%) 25 (20.7%)
Yes 1,036 (63.7%) 28 (87.5%) 96 (79.3%)
Presence of Chronic Diseases*
Hypertension 191 (11.8%) 5 (15.6%) 15 (12.4%)
Diabetes 32 (2.0%) 4 (3.3%)
Cholesterol 267 (16.6%) 9 (28.1%) 25 (20.7%)
Pulmonary 58 (3.6%) 1 (3.1%) 3 (2.5%)
Cardiac 101 (6.3%) 9 (28.1%) 16 (12.2%)
Thrombose 8 (0.5%) 1 (3.2%)
Digestive 247 (15.4%) 10 (31.3%) 31 (25.8%)
Neurological 180 (11.2%) 7 (21.9%) 29 (24.0%)
Allergies 572 (35.5%) 16 (50.0%) 59 (48.8%)
Oncological 44 (2.8%) 3 (9.7%) 4 (3.4%)
Hyperuricemia 25 (1.6%) 2 (6.3%) 4 (3.3%)
Urinary 74 (4.7%) 3 (9.4%) 6 (5.0%)
Rheumatic 82 (5.3%) 5 (16.7%) 13 (11.3%)
*

Sample size is not constant due to missing values in: Hypertension (n = 1,614), Diabetes (n = 1,609), Cholesterol (n = 1,608), Pulmonary (n = 1,615), Cardiac (n = 1,615), Thrombose (n = 1,614), Digestive (n = 1,609), Neurological (n = 1,611), Allergies (n = 1,612), Oncological (n = 1,578), Hyperuricemia (n = 1,588), Urinary (n = 1,586), Rheumatic (n = 1,548).

Participants with depression symptoms: Diabetes (n = 31), Thrombose (n = 31), Oncological (n = 31), Rheumatic (n = 30).

Participants with anxiety symptoms: Diabetes (n = 120), Thrombose (n = 120), Digestive (n = 120), Oncological (n = 119), Hyperuricemia (n = 120), Urinary (n = 120), Rheumatic (n = 115).

DK/DA, Didn't know/ Didn't answer.